NCT05299944View on ClinicalTrials.gov

Reducing Pain and Opioid Use With CBD

PHASE2RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 8, 2022

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Opioid Use Disorder
Interventions
DRUG

Cannabidiol

The current study will directly test the hypothesis that a moderate dose of CBD leads to a reduction in opioid consumption, opioid craving, pain, peripheral markers of inflammation, and anxiety, as well as changes in sleep, AEA, and cognition.

DRUG

Placebo

Placebo arm

Trial Locations (2)

80045

RECRUITING

University of Colorado - Anschutz Medical Campus, Aurora

RECRUITING

University of Colorado Denver, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER